| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 02/12/2002 | US6346413 Polymer arrays |
| 02/07/2002 | WO2002010218A1 Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials |
| 02/07/2002 | WO2002009793A1 Device for treating immune diseases |
| 02/07/2002 | US20020015699 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 02/06/2002 | EP1176987A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |
| 01/31/2002 | WO2002007707A2 Linkage of agents using microparticles |
| 01/31/2002 | WO2000072869A9 Methods for producing 5'-nucleic acid-protein conjugates |
| 01/31/2002 | US20020012948 Metallopeptide combinatorial libraries and applications |
| 01/31/2002 | CA2797652A1 Multi-component biological transport systems |
| 01/31/2002 | CA2415345A1 Linkage of agents using microparticles |
| 01/30/2002 | EP1175235A1 Modified protein matrices |
| 01/30/2002 | CN1333785A Interferon-beta fusion proteins and uses |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/24/2002 | WO2002006384A1 Activated modular grafted polymeric surfaces |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001036595A3 Methods for conditional transgene expression and trait removal in plants |
| 01/23/2002 | EP1173557A1 Method for encapsulating macromolecules and/or particles and use thereof |
| 01/22/2002 | CA1341334C Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 01/17/2002 | US20020006604 Solid support for the detection of preferential compounds in sample |
| 01/16/2002 | EP1171592A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain |
| 01/16/2002 | EP1171463A2 Peptide homodimers and peptide heterodimers, derived from interferon alpha 2 |
| 01/16/2002 | EP1171098A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes |
| 01/09/2002 | EP1170014A1 Proteoglycan, a bioactive substance from plants |
| 01/09/2002 | EP1169646A2 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 01/09/2002 | CN1330675A Polyamide chains of precise length, methods to manufacture them and their conjugates with protein |
| 01/01/2002 | US6335179 Directed evolution of thermophilic enzymes |
| 01/01/2002 | US6335017 Compositions and methods for treating viral infections |
| 12/27/2001 | WO2001098497A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | WO2001098458A2 Methods for immobilizing polypeptides |
| 12/27/2001 | WO2001098362A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/27/2001 | WO2001046214A3 Compound comprising a nucleic acid moiety and an organo-silane moiety |
| 12/27/2001 | CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | CA2412011A1 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/19/2001 | EP1163004A2 Immunoadsorber for use in sepsis therapy |
| 12/18/2001 | US6331175 Method and kit for imaging and treating organs and tissues |
| 12/13/2001 | DE10027397A1 Oberfläche zur Immobilisierung von Liganden Surface for immobilization of ligands |
| 12/12/2001 | EP1161450A1 Bone stimulating factor |
| 12/11/2001 | US6329512 Isolating specific outer membrane proteins from haemophilus strain from cell paste using extraction, concentration and purification steps; for increasing immunogenicity of streptococcus capsular polysaccharide used as vaccine |
| 12/11/2001 | US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating |
| 12/06/2001 | WO2001092883A2 Surface for the immobilisation of ligands |
| 12/06/2001 | WO2001092452A1 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 12/06/2001 | CA2413855A1 Surface for the immobilisation of ligands |
| 12/06/2001 | CA2408226A1 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 12/05/2001 | EP1159299A1 Mammalian cytokines; related reagents and methods |
| 12/05/2001 | CN1325405A Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 12/04/2001 | CA2278883C Very large scale immobilized peptide synthesis |
| 12/04/2001 | CA2053829C Vaccines against equine herpesviruses and the preparation thereof |
| 11/29/2001 | US20010047085 Adding to the protein solution a cyclodextrin in an amount sufficient to form a stable complex with the protein, lyophilizing, recovering lyophilized protein/cyclodextrin complex, heating complex to inactivate viruses |
| 11/26/2001 | CA2346163A1 Complex for transferring an anionic substance of interest into a cell |
| 11/21/2001 | CN1323313A Process for the preparation of resin-bound cyclic peptides |
| 11/21/2001 | CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide |
| 11/21/2001 | CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 11/21/2001 | CN1323213A Blood-brain barrier therapeutics |
| 11/21/2001 | CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof |
| 11/20/2001 | US6319693 Cloning of chicken anemia virus DNA |
| 11/08/2001 | WO2001083827A1 High density protein arrays for screening of protein activity |
| 11/08/2001 | WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 11/08/2001 | WO2000061194A3 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |
| 11/08/2001 | CA2408291A1 High density protein arrays for screening of protein activity |
| 11/01/2001 | WO2001081425A1 Use of a secondary cell wall polymer of procaryotic microorganisms |
| 11/01/2001 | US20010036629 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 11/01/2001 | CA2407639A1 Using the secondary cell wall polymers of prokaryotic microorganisms |
| 10/31/2001 | EP0693085B1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
| 10/30/2001 | US6310189 Nucleotides and analogs having photoremoveable protecting groups |
| 10/30/2001 | US6309822 Detecting adjustments in nucleotide sequences; provide probes, mix probes with nucleic acids, detect binding of probes to preferential nucleotide sequences |
| 10/25/2001 | WO2001079300A1 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor |
| 10/23/2001 | US6306822 Phosphopeptides and methods of treating bone diseases |
| 10/23/2001 | CA2125043C Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 10/18/2001 | WO2001077687A2 Prion-binding peptidic ligands and methods of using same |
| 10/18/2001 | WO2001077676A1 T2r taste receptors and genes encoding same |
| 10/18/2001 | WO2001077182A1 Antibody/carrier complex, process for producing the same, method of controlling antigen-antibody reaction by using the same and immunoassay method |
| 10/18/2001 | WO2001076662A1 Adsorbents for dilated cardiomyopathy |
| 10/18/2001 | US20010031839 Azlactone-derivatized polyamides |
| 10/18/2001 | CA2405568A1 Prion-binding peptidic ligands and methods of using same |
| 10/18/2001 | CA2403003A1 T2r taste receptors and genes encoding same |
| 10/16/2001 | CA2144104C Peptide derivatives having binding activity to modified low density lipoprotein |
| 10/10/2001 | EP1141391A1 Method for making a biochip and biochip |
| 10/10/2001 | EP1141375A1 Metallopeptide combinatorial libraries and applications |
| 10/10/2001 | CN1316436A Process for preparing water-soluble slow-releasing recombination protein |
| 10/04/2001 | EP1137941A1 Protein scaffolds for antibody mimics and other binding proteins |
| 10/04/2001 | EP1137812A1 Dna-protein fusions and uses thereof |
| 10/04/2001 | EP1137690A2 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 10/04/2001 | EP1137669A1 Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
| 10/04/2001 | EP1137442A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 09/27/2001 | CA2723664A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/26/2001 | EP1135486A1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/26/2001 | EP1135405A1 DNA ENCODING PROTEINS THAT INHIBIT Hsp70 FUNCTION |
| 09/26/2001 | EP1135155A1 Methods of inhibiting ectopic calcification |
| 09/26/2001 | EP0902834A4 Stable avidin composition and methods using same |
| 09/26/2001 | CN1314416A 17,21-ester substituted 1,4-diene-3-keto-9,11-epoxy steroid compound |
| 09/26/2001 | CN1071760C N-terminally chemically modified protein composition and methods |
| 09/22/2001 | CA2301959A1 Peptide having affinity for coagulation factor viii |
| 09/20/2001 | WO2000012587A8 Polyamide chains of precise length, methods to manufacture them and their conjugates |
| 09/19/2001 | EP1133519A2 Functional antagonists of hedgehog activity |
| 09/19/2001 | EP0700302B1 Device for treating diabetes mellitus |
| 09/19/2001 | CN1313343A N-terminal modified protein compositions and methods therefor |
| 09/18/2001 | US6291183 A plurality of oligonucleotide linker molecules are attached on a planar solid support, photoremovable groups react with terminal ends of oligonucleotides, substrates exposed to light activate binding at selected areas; peptide synthesis |